Patents by Inventor Antonio Molina-Fernandez

Antonio Molina-Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230276801
    Abstract: The present invention is directed to methods and compositions for increasing a growth characteristic of a plant, increasing nutrient use efficiency of a plant, or improving a plant’s ability to overcome biotic or abiotic stress comprising applying a composition comprising mixed linked ?-1,3/?-1,4 glucans (MLGs) to a plant, plant part, propagation material of the plant, or to the soil, hydroponic solution or growth media in which a target plant is growing.
    Type: Application
    Filed: July 27, 2021
    Publication date: September 7, 2023
    Inventors: Hugo MÉLIDA MARTÍNEZ, Diego REBAQUE MORÁN, Lucía JORDÁ MIRÓ, Irene DEL HIERRO GARCÍA, Laura BACETE CANO, Gemma LOPEZ, Rosa Maria PÉREZ JIMÉNEZ, Frédéric BRUNNER, Antonio MOLINA FERNÁNDEZ
  • Patent number: 10196649
    Abstract: The invention relates to a method of increasing the resistance to one or more pathogens, preferably fungal or bacterial pathogens, in a monocotyledonous or dicotyledonous plant or a part of a plant, for example in an organ, tissue, a cell or a part of a plant cell, for example in an organelle, wherein a DNA sequence which codes for YODA protein or wherein an endogenous DNA sequence which codes for a YODA protein is increased in the plant or plant cell in comparison with the original, or wild-type, plant. The invention also relates to plants, to parts of a plant, for example an organ, tissue, a cell or a part of a plant cell, for example an organelle, which are obtained by the above methods, and to the corresponding propagation material.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: February 5, 2019
    Assignee: UNIVERSIDAD POLITECNICA DE MADRID
    Inventors: Antonio Molina Fernandez, Lucia Jorda Miro, Clara Sanchez Rodriguez, Sara Sopena Torres, Gemma Lopez Garcia, Eva Miedes Vicente, Andrea Sanchez Vallet, Viviana Pamela Escudero Welsch
  • Publication number: 20160108424
    Abstract: The invention relates to a method of increasing the resistance to one or more pathogens, preferably fungal or bacterial pathogens, in a monocotyledonous or dicotyledonous plant or a part of a plant, for example in an organ, tissue, a cell or a part of a plant cell, for example in an organelle, wherein a DNA sequence which codes for YODA protein or wherein an endogenous DNA sequence which codes for a YODA protein is increased in the plant or plant cell in comparison with the original, or wild-type, plant. The invention also relates to plants, to parts of a plant, for example an organ, tissue, a cell or a part of a plant cell, for example an organelle, which are obtained by the above methods, and to the corresponding propagation material.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 21, 2016
    Inventors: Antonio MOLINA FERNANDEZ, Lucia JORDA MIRO, Clara SANCHEZ RODRIGUEZ, Sara SOPENA TORRES, Gemma LOPEZ GARCIA, Eva MIEDES VICENTE, Andrea SANCHEZ VALLET, Viviana Pamela ESCUDERO WELSCH
  • Publication number: 20020133846
    Abstract: The present invention concerns a method of protecting plants from pathogen attack through synergistic disease resistance attained by applying a conventional microbicide to immunomodulated plants. Immunomodulated plants are those in which SAR is activated and are therefore referred to as “SAR-on” plants. Immunomodulated plants may be provided in at least three different ways: by applying to plants a chemical inducer of SAR such as BTH, INA, or SA; through a selective breeding program based on constitutive expression of SAR genes and/or a disease-resistant phenotype; or by transforming plants with one or more SAR genes such as a functional form of the NIM1 gene. By concurrently applying a microbicide to an immunomodulated plant, disease resistance is unexpectedly synergistically enhanced; i.e., the level of disease resistance is greater than the expected additive levels of disease resistance.
    Type: Application
    Filed: December 12, 2001
    Publication date: September 19, 2002
    Inventors: John Andrew Ryals, Leslie Bethards Friedrich, Scott Joseph Uknes, Antonio Molina-Fernandez, Kay Ann Lawton
  • Patent number: 6147281
    Abstract: The present invention relates to novel antipathogenic peptides, to DNA sequences encoding said peptides, to vectors comprising said DNA sequences, to transgenic plants comprising a DNA sequence encoding said peptides, to compositions containing anti-pathogenic peptides and to the use of said peptides and compositions for controlling plant pathogens, Also comprised are methods of preparing antipathogenic peptides or compositions containing same and transgenic plants able to synthesize anti-pathogenically effective amounts of said peptides.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: November 14, 2000
    Assignee: Universidad Politecnia de Madrid
    Inventors: Francisco Garcia-Olmedo, Antonio Molina Fernandez
  • Patent number: 6031153
    Abstract: The present invention concerns a method of protecting plants from pathogen attack through synergistic disease resistance attained by applying a conventional microbicide to immunomodulated plants. Immunomodulated plants are those in which SAR is activated and are therefore referred to as "SAR-on" plants. Immunomodulated plants may be provided in at least three different ways: by applying to plants a chemical inducer of SAR such as BTH, INA, or SA; through a selective breeding program based on constitutive expression of SAR genes and/or a disease-resistant phenotype; or by transforming plants with one or more SAR genes such as a functional form of the NIM1 gene. By concurrently applying a microbicide to an immunomodulated plant, disease resistance is unexpectedly synergistically enhanced; i.e., the level of disease resistance is greater than the expected additive levels of disease resistance.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: February 29, 2000
    Assignee: Novartis AG
    Inventors: John Andrew Ryals, Leslie Bethards Friedrich, Scott Joseph Uknes, Antonio Molina-Fernandez, Wilhelm Ruess, Gertrude Knauf-Beiter, Ruth Beatrice Kung, Helmut Kessmann, Michael Oostendorp